Simplex Trading’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Simplex Trading's BTAL Position: Q2 2026 in Review
Simplex Trading increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 1,041% in Q2 2026, buying an estimated $113K and bringing the position to 10,151 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #5395.
Simplex Trading first reported a position in BTAL in Q4 2023 and has held it in 6 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Simplex Trading held 10,151 shares of AGF US Market Neutral Anti-Beta Fund worth $113K as of Q2 2026.
- Simplex Trading bought 9,261 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $113K.
- AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5395 holding.
- Simplex Trading first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and has held it in 6 quarters since.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.